p53 and Ki-67 as markers of radioresistance in head and neck carcinoma
✍ Scribed by Christian Couture; Hélène Raybaud-Diogène; Bernard Têtu; Isabelle Bairati; Danielle Murry; Josée Allard; André Fortin
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 112 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Mutations of the p53 tumor-suppressor gene are common in squamous cell carcinoma of the head and neck (scchn) and may portend a worse prognosis. human papillomavirus (hpv) represents another potential prognostic factor for scchn. the oncogenic potential of hpv may be due to the abili
noma recurrence after 5 years of follow-up (N Å 30) and those with carcinoma 1 The Matsunaga-Conte Prostate Cancer Rerecurrence (N Å 17). Gleason grade, clustered p53 immunostaining, Ki-67 immunosearch Center and the Scott Department of Urolstaining, and AI were determined by standard techniques. og
Background. Head and neck squamous cell carcinomas (HNSCC) are treated by surgery or radiotherapy. Tumor cell death-related markers, such as p21 and Ki-67, may predict response to therapy and improve treatment choice. We evaluated and compared the effect of their coexpression between patients treate
Background and Objectives: p53 and Ki-67 are but two markers being evaluated for their predictive value in prostate cancer. The purpose of this study was to compare p53 and Ki-67 with age, stage, Gleason score, and ploidy for their prognostic abilities in prostate cancer. Methods: Prostate cancer sp
## BACKGROUND. The ability to make a precise preoperative diagnosis is a valuable and effective method in improving the prognosis of patients with gastric carcinoma. The authors examined retrospectively whether preoperative histopathologic analysis with p53 protein, Ki-67 labeling index, and DNA p